The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Tramadol Composition For Ophthalmic Use - EP3348260

The patent EP3348260 was granted to Farmalider on Jun 2, 2021. The application was originally filed on Sep 5, 2016 under application number EP16843709A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3348260

FARMALIDER
Application Number
EP16843709A
Filing Date
Sep 5, 2016
Status
Opposition Rejected
Mar 29, 2024
Publication Date
Jun 2, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRATAGEMMar 2, 2022- -

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTES2540151
INTERNATIONAL-SEARCH-REPORTWO2012136969
INTERNATIONAL-SEARCH-REPORTWO2013150277
OPPOSITIONEP2862565
OPPOSITIONEP3348260
OPPOSITIONWO2012136969
OPPOSITIONWO2013150277
OPPOSITIONWO9717948

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents